BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Diagnosis
6 results:

  • 1. Quantitative profiling of genes associated with cancer pathways in brain tumors.
    Majerčíková Z; Dibdiaková K; Galanda M; Galanda T; Richterová R; Kolarovszki B; Račay P; Hatok J
    Klin Onkol; 2023; 36(3):224-233. PubMed ID: 37353350
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
    Li H; He J; Li M; Li K; Pu X; Guo Y
    Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Emerging glioneuronal and neuronal tumors: case-based review.
    Lim SD; Kim SI; Park JW; Won JK; Kim SK; Phi JH; Chung CK; Choi SH; Yun H; Park SH
    Brain Tumor Pathol; 2022 Apr; 39(2):65-78. PubMed ID: 35048219
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preclinical evaluation of binimetinib (mek162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
    J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
    Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
    Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung cancer Mutation Consortium.
    Steuer CE; Behera M; Berry L; Kim S; Rossi M; Sica G; Owonikoko TK; Johnson BE; Kris MG; Bunn PA; Khuri FR; Garon EB; Ramalingam SS
    Cancer; 2016 Mar; 122(5):766-72. PubMed ID: 26695526
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.